Significance of the pulsatility index in the evaluation of hemodynamic changes in peripheral arterial circulation in the obese treated with orlistat
Abstract
Background/Aim. Prolonged hyperinsulinemia accelerates the process of endothelial dysfunction and arteriosclerotic changes affecting the development of cardiovascular and cerebrovascular diseases. There are various measuring techniques for the evaluation of early functional changes in the arterial wall such are flow-mediated endothelium-dependent vasodilation, impulse wave analysis, intima-media thickness assessment, venous plethysmography and so on, however, each having certain limitations in results interpretation. The aim of this study was to indicate the correlation of pulsatility index that shows peripheral arterial contractility with the changes in metabolic parameters under the conditions of insulin resistance. Method. The study included a total of 35 healthy obese subjects with the values of body mass index more than 30 kg/m2 randomized with double blind design into two groups: placebo and orlistat. The extent of insulin sensitivity was calculated on the basis of the values of glycemia and insulinemia using the formula (?). Results. The obtained results suggest a statistically significant improvement in the pulsatility index in the group orlistat (p < 0.002), while there was no such improvement in the placebo group. Conclusion. The results obtained in this study indicate the improvement in insulin sensitivity within early arteriosclerosis as a significantly favorable factor for peripheral arterial circulation additionally supported by the reduction in the level of lipid fractions, especially triglycerides. Early hemodynamic changes under the conditions of the reduced insulin resistance are characterized by the increase in arterial wall contractility evaluated with pulsatility index determination.
References
Campbell P, Gerish J. Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity. J Clin Endocrinol Metab 1990; 70(4): 1114‒8.
Bougneres PF, Artavia-Loria P, Henry S, Basdevant A, Castaño L. Increased basal glucose production and utilisation in children with recent obesity versus adults with long-term obesity. Dia-betes 1989; 38(4): 477‒83.
Lillioja S, Bogardus C. Obesity and insulin resistance: lessons learned from Pima Indians. Diabetes Metab Rev 1988; 4(4): 517‒40.
Laakso M, Edelman SV, Brechtel G, Baron AD. Decreases effect of insulin stimulate sceletal blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 1990; 85(6): 1844‒52.
Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesi-ty to insulin resistance and type 2 diabetes. Nature 2006; 444(7121): 840–6.
Schmidt AM, Stern DM. Hyperinsulinemia and vascular dys-function: the role of nuclear factor-kappa B, yet again. Circ Res 2000; 87(9): 722‒4.
Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrande D, et al. Close ralation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26(5): 1235‒41.
Stühlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002; 287(11): 1420‒6.
Böhm F, Ahlborg G, Pernow J. Endothelin-1 inhibits endotheli-um-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis. Clin Sci (Lond) 2002; 102(3): 321‒7.
Cardillo C, Nambi SS, Kilcoyne CM, Choucair WK, Katz A, Quon MJ, et al. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 1999; 100(8): 820‒5.
Pearson JD. Normal endothelial cell function. Lupus 2000; 9(3): 183‒8.
Laroia ST, Ganti AK, Laroia AT, Tendulkar KK. Endothelium and the lipid metabolism: the current understanding. Int J Cardiol 2003; 88(1): 1‒9.
Cardillo C, Kilcoyne CM, Cannon RO 3rd, Panza JA. Interactions between nitric oxide and endothelin in the regulation of vas-cular tone of human resistance vessels in vivo. Hypertension 2000; 35(6): 1237‒41.
Daiber A, Steven S, Weber A, Shuvaev VV, Muzykantov VR, La-her I, et al. Targeting vascular (endothelial) dysfunction. Br J Pharmacol 2017; 174(12): 1591‒619.
Su JB. Vascular endothelial dysfunction and pharmacological treatment. World J Cardiol 2015; 7(11): 719‒41.
Hristova K. The Role of Noninvasive Imaging for Detection High Risk Patients with Subclinical Atherosclerosis. Arch Clin Hypertens 2016; 1(1): 004‒012.
Sitia S, Tomasoni L, Atzeni F, Ambrosio G, Cordiano C, Catapano A, et al. From endothelial dysfunction to atherosclerosis. Au-toimmun Rev 2010; 9(12): 830–4.
Jacotot B, Castaigne A. Coronary atherosclerosis. In: Jacotot B, editor. Coronary Artery Disease. Lonodon: PIL; 1996. (French)
Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lan-cet 1989; 2(8670): 997‒1000.
Zdravković M. Atherosclerosis – development and consequenc-es. In: Kažić T, Zdravković M, editors. Clinical Cardiovascular Pharmacology. Beograd: Integra; 1997. p. 123‒42. (Serbian)
Tooke J. The association between insulin resistance and endo-theliopathy. Diabetes Obes Metab 1999; 1(Suppl 1): 17‒22.
Schiffrin EL. Canadian Institutes of Health Research Multidis-ciplinary Research Group on Hypertension. Beyond blood pressure: the endothelium and atherosclerosis progression. Am J Hypertens 2002; 15(10 Pt 2): 115S‒22S.
Shichiri M, Yokokura M, Marumo F, Hirata Y. Endothelin-1 in-hibits apoptosis of vascular smooth muscle cells induced by ni-tric oxide and serum deprivation via MAP kinase pathway. Arterioscler Thromb Vasc Biol 2000; 20(4): 989‒97.
Bressler P, Bailey SR, Matsuda M, DeFronzo RA. Insulin re-sistance and coronary artery disease. Diabetologia 1996; 39(11): 1345‒50.
Fuster V, Ross R, Topol EJ. Atherosclerosis and coronary artery disease. New York, NY: Lippincott-Raven; 1996. p. 387‒99.
Healy B. Endothelial cell dysfunction: an emerging endocrino-pathy linked to coronary disease. J Am Coll Cardiol 1990; 16(2): 357‒8.
Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362(6423): 801‒9.
Corretti MC, Plotnick GD, Vogel RA. Technical aspects of eval-uating brachial artery vasodilatation using high-frequency ul-trasound. Am J Physiol 1995; 268(4 Pt 2): 1397‒404.
Li J, Zhao SP, Li XP, Zhuo QC, Gao M, Lu SK. Non-invasive detection of endothelial dysfunction in patients with essential hypertension. Int J Cardiol 1997; 61(2): 165‒9.
Clarkson P, Celermajer DS, Powe AJ, Donald AE, Henry RMA, Deanfield JE. Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature cor-onary disease. Circulation 1997; 96(10): 3378–83.
Patil P, Shejol S, Pathak KP. Assessment endothelial dysfunction in essential hypertension duration of 2 years by ultrasonogra-phy. Indian J Appl Res 2015; 5(11): doi 10.15373/2249-555X.
Kozakova M, Palombo C. Vascular Ultrasound and Cardiovascu-lar Risk Assessment. Austin J Vasc Med 2016; 3(1): 1015.
Qu B, Qu T. Causes of changes in carotid intima-media thick-ness: a literature review. Cardiovasc Ultrasound 2015; 13: 46.
Bernstein E. Non-invasive diagnosis in vascular disease. St. Louis: CV Mosby Co; 1986.
Zierler RE, Dawson DL. Strandness's Duplex Scanning in Vas-cular Disorders. New York: Raven Press; 2015.
Carter S, Tate RB. Value of toe pulse waves in addition to sys-tolic pressures in the assessment of the severity of peripheral arterial disease and critical limb ischemia. J Vasc Surg 1996; 24(2): 258‒65.
Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Ham-man R, et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circu-lation 1996; 93(10): 1809‒17.
Allan PL, Mowbray PI, Lee AJ, Fowkes FG. Relationship be-tween carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Ar-tery Study. Stroke 1997; 28(2): 348‒53.
Bokemark L, Wikstrand J, Attvall S, Hulthe J, Wedel H, Fagerberg B. Insulin resistance and intima-media thickness in the carotid and femoral arteries of clinically healthy 58-year-old men. The Atherosclerosis and Insulin Resistance Study (AIR). J Intern Med 2001; 249(1): 59‒67.
Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucosetolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22(9): 1462‒70.
Wingard DL, Barrett-Connor E. Family history of diabetes and cardiovascular disease risk factors and mortality among euglycemic, borderline hyperglycemic,and diabetic adults. Am J Epidemiol 1987; 125(6): 948‒58.
Rewers M, Shetterly SM, Baxter J, Marshall JA, Hamman RF. Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin-dependent di-abetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol 1992; 135(12): 1321‒30.
Mykkänen L, Laakso M, Pyörälä K. Asymptomatic hyperemia and atherosclerotic vascular disease in the elderly. Diabetes Care 1992; 15(8): 1020‒30.
Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kubota M, et al. Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid ar-tery. Diabetologia 1995; 38(5): 585‒91.
Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 2011; 34 Suppl 2: S285‒90.
Carlos TM, Harlan JM. Leukocyte-endothelial adhesion mole-cules. Blood 1994; 84(7): 2068‒101.
Sena CM, Pereira AM, Seiça R. Endothelial dysfunction - a ma-jor mediator of diabetic vascular disease. Biochim Biophys Ac-ta 2013; 1832(12): 2216‒31.
Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Duci-metieère P, et al. Pulse pressure: a predictor of long-term cardi-ovascular mortality in a French male population. Hyperten-sion 1997; 30(6): 1410‒5.
Hirai T, Sasayama S, Kawasaki T, Yagi S. Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circu-lation 1989; 80(1): 78‒86.
O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002; 15(5): 426‒44.
Greenwald SE. Pulse pressure and arterial elasticity. QJM 2002; 95(2): 107‒12.
Van Bortel LM, Struijker-Boudier HA, Safar ME. Pulse pres-sure, arterial stiffness, and drug treatment of hypertension. Hypertension 2001; 38(4): 914-21.
O'Rourke MF, Mancia G. Arterial stiffness. J Hypertens 1999; 17(1): 1‒4.
Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardi-ovascular diseases. Circulation 2003; 107(22): 2864‒9.
Klemsdal TO, Andersson TL, Matz J, Ferns GA, Gjesdal K, Anggård EE. Vitamin E restores endothelium dependent vaso-dilatation in cholesterol fed rabbits: in vivo measurements by photoplethysmography. Cardiovasc Res 1994; 28(9): 1397‒402.
Chowienczyk PJ, Kelly RP, MacCallum H, Millasseau SC, Anders-son TL, Gosling RG, et al. Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol 1999; 34(7): 2007‒14.
Shinozaki K, Kashiwagi A, Nishio Y, Okamura T, Yoshida Y, Ma-sada M, et al. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta. Diabetes 1999; 48(12): 2437‒45.
Zhang H, Dellsperger KC, Zhang C. The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update. Basic Res Cardiol 2012; 107(1): 237.
Domingueti CP, Dusse LM, Carvalho Md, de Sousa LP, Gomes KB, Fernandes AP. Diabetes mellitus: The linkage between ox-idative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complications 2016; 30(4): 738‒45.
Reaven GM, Lithell H, Landsberg L. Hypertension and associat-ed metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334(6): 374‒81.
Reaven G, Segal K, Hauptman J, Boldrin M, Lucas C. Effect of orlistat-assisted weight loss in decreasing coronary heart dis-ease risk in patients with syndrome X. Am J Cardiol 2001; 87(7): 827‒31.